We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor-infiltrating lymphocytes in an experimental carcinoma model

    Metformin is a widely used antidiabetic biguanide. Retrospective data demonstrated the association of metformin use with survival benefit in multiple...

    Heba Mohamed Zaki, Khadiga Mohamed Ali, ... Osama Hussein in BMC Research Notes
    Article Open access 02 January 2024
  2. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma

    Tumor-associated microglia and blood-derived macrophages (TAMs) play a central role in modulating the immune suppressive microenvironment in glioma....

    Fatih Yalcin, Hannah Haneke, ... Helmut Kettenmann in Acta Neuropathologica Communications
    Article Open access 02 April 2024
  3. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization

    Glioblastoma (GBM) is a common primary central nervous system tumor. Although the multimodal integrated treatment for GBM has made great progress in...

    Caiyan Gao, Yan Nie in Metabolic Brain Disease
    Article 01 February 2024
  4. Cytokines and Chemokines in Tumor Growth and Progression

    The significance of cytokines as signaling molecules, which has long been acknowledged, is expanding as a result of their connection to malignancies...
    Manzoor Ahmad Mir, Mina Rashid, Nusrat Jan in Cytokine and Chemokine Networks in Cancer
    Chapter 2023
  5. Extracellular vesicles produced by irradiated endothelial or Glioblastoma stem cells promote tumor growth and vascularization modulating tumor microenvironment

    Background

    Glioblastoma (GBM) is the most lethal primary brain tumor in adult, characterized by highly aggressive and infiltrative growth. The current...

    Giorgia Castellani, Mariachiara Buccarelli, ... Lucia Ricci-Vitiani in Cancer Cell International
    Article Open access 12 February 2024
  6. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth

    Background

    B-cell lymphoma 2 (Bcl-2) family proteins are key regulators of apoptosis, which possess four conserved Bcl-2 homologies (BH) domains....

    Yihua Lin, Yiling Zhao, ... Qian-Qian Zhang in BMC Cancer
    Article Open access 26 May 2023
  7. Tumoral P2Y2 receptor modulates tumor growth and host anti-tumor immune responses in a syngeneic murine model of oral cancer

    Head and neck squamous cell carcinomas (HNSCCs) are a heterogenous group of tumors and among the top 10 most common cancers and they arise from the...

    Kevin Muñoz Forti, Lucas T. Woods, ... Gary A. Weisman in Purinergic Signalling
    Article 12 August 2023
  8. CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth

    Background

    Though the CXCR2 chemokine receptor is known to play a key role in cancer growth and response to therapy, a direct link between expression...

    J. Yang, K. Bergdorf, ... A. Richmond in Molecular Cancer
    Article Open access 03 June 2023
  9. Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases

    Liver is the third most common organ for breast cancer (BC) metastasis. Two main histopathological growth patterns (HGP) exist in liver metastases...

    Sophia Leduc, Maxim De Schepper, ... Christine Desmedt in npj Breast Cancer
    Article Open access 15 December 2023
  10. Tumor Microenvironment

    In this chapter, we will learn that the tumor microenvironment is a stroma of normal cells supporting cancer cells. Tumors act like parasites that...
    Carsten Carlberg, Eunike Velleuer, Ferdinand Molnár in Molecular Medicine
    Chapter 2023
  11. The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications

    Lipid metabolism is widely reprogrammed in tumor cells. Lipid droplet is a common organelle existing in most mammal cells, and its complex and...

    Boer Deng, Weimin Kong, ... Victoria Bae-Jump in Journal of Translational Medicine
    Article Open access 18 March 2024
  12. FK228 suppress the growth of human malignant pleural mesothelioma tumor independent to epithelioid or non-epithelioid histology

    Human malignant pleural mesothelioma (hMPM) is an aggressive, rare disease with a poor prognosis. Histologically, MPM is categorized into...

    James Mei-Lin Chan, Yuan-Ching Chang, ... Wen-Chien Huang in Molecular Medicine
    Article Open access 31 May 2024
  13. Histopathological growth patterns of neuroendocrine tumor liver metastases

    Histopathological growth patterns (HGPs) of liver metastases represent a potential biomarker for prognosis after resection. They have never been...

    Y. Meyer, A. Bohlok, ... C. Verhoef in Clinical & Experimental Metastasis
    Article Open access 14 May 2023
  14. Circular RNA ZNF800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer

    Background

    Cancer stem cells form a rare cell population in tumors that contributes to metastasis, recurrence and chemoresistance in cancer patients....

    Vimalan Rengganaten, Chiu-Jung Huang, ... Kong Bung Choo in BMC Cancer
    Article Open access 10 November 2023
  15. Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth

    Background

    The pancreatic microenvironment has a defensive role against cancer but it can acquire tumor-promoting properties triggered by multiple...

    Andrea Resovi, Perla Persichitti, ... Dorina Belotti in Journal of Experimental & Clinical Cancer Research
    Article Open access 09 August 2023
  16. Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice

    Ketogenic diets (KDs) can improve the well-being and quality of life of breast cancer patients. However, data on the effects of KDs on mammary tumors...

    Meret Grube, Arno Dimmler, ... Wilko Thiele in Clinical & Experimental Metastasis
    Article Open access 09 December 2023
  17. Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is characterized by rapid progression and poor prognosis. Understanding the genetic mechanisms that...

    Wenbo Yang, Hongze Chen, ... Le Li in Journal of Translational Medicine
    Article Open access 11 December 2023
  18. Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer

    Our previous study showed that pyridoxine 5’-phosphate oxidase (PNPO) is a tissue biomarker of ovarian cancer (OC) and has a prognostic implication...

    **n Li, Wencai Guan, ... Lingyun Zhang in Apoptosis
    Article Open access 13 April 2024
  19. Biological role of matrix stiffness in tumor growth and treatment

    In recent years, the biological role of changes in physical factors in carcinogenesis and progression has attracted increasing attention. Matrix...

    Boer Deng, Ziyi Zhao, ... Chunxiao Zhou in Journal of Translational Medicine
    Article Open access 22 November 2022
  20. CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment

    Anaplastic thyroid carcinoma (ATC) is an extremely malignant type of endocrine cancer frequently accompanied by extrathyroidal extension or...

    Zongfu Pan, Tong Xu, ... Minghua Ge in Molecular Cancer
    Article Open access 03 October 2022
Did you find what you were looking for? Share feedback.